BNP Paribas Knock-Out TYL/ DE000PG3GBN6 /
2024-07-26 9:47:44 PM | Chg.+6.81 | Bid10:00:41 PM | Ask10:00:41 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
11.99EUR | +131.47% | - Bid Size: - |
- Ask Size: - |
Tyler Technologies C... | 462.8728 USD | 2078-12-31 | Call |
GlobeNewswire
06-27
Redwood Feeds Snak-King’s Appetite for Transportation Innovation Amid Supply Chain Disruption
GlobeNewswire
06-26
Basis Technologies Improves Planning Capabilities for Advertisers Through AI-Powered Media Automatio...
GlobeNewswire
06-18
Kite Realty Group Trust to Report Second Quarter 2024 Financial Results on July 30, 2024
Newsfile Corp
06-18
UneeQ Transforms Enterprise AI by Allowing Organizations to Leverage Their AI Investments and Create...
GlobeNewswire
06-17
TRULY® HARD SELTZER HEATS UP U.S. SOCCER PARTNERSHIP IN TIME FOR SUMMER KICK-OFF
GlobeNewswire
06-17
nCino Deploying Banking Advisor, a Generative AI Solution to Drive New Efficiencies in Financial Ins...
GlobeNewswire
06-14
Hymson Brings its Laser Solutions for Battery Innovation to The Battery Show Europe 2024
GlobeNewswire
06-13
VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BE...
GlobeNewswire
06-13
Infinidat Wins Multiple Awards from Storage Magazine, UK at the 2024 Storries XXI
GlobeNewswire
06-12
United Lithium Announces Drill Results for Lithium Pegmatites D & E Confirming Strike Length of over...
GlobeNewswire
06-10
Silvaco to Announce First Quarter 2024 Financial Results and Provide Second Quarter and Full Year 20...
GlobeNewswire
06-07
AMERICAN SALARS FILES NI 43-101 TECHNICAL REPORT ON BLACKROCK SOUTH LITHIUM BRINE PROJECT
GlobeNewswire
06-05
Cipher Mining Announces Significant Upgrades to its Mining Fleet and Increases Target Hash Rate and ...
GlobeNewswire
06-05
VYNE Therapeutics Announces Dosing of First Subject in Phase 2b Vitiligo Trial of Novel BET Inhibito...
GlobeNewswire
06-05
ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psori...